SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001144204-17-020551
Filing Date
2017-04-14
Accepted
2017-04-14 16:31:12
Documents
52
Period of Report
2017-04-14

Document Format Files

Seq Description Document Type Size
1 6-K/A v463886_6ka.htm 6-K/A 12276
  Complete submission text file 0001144204-17-020551.txt   3337012

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT aktx-20160630.xml EX-101.INS 834031
3 XBRL TAXONOMY EXTENSION SCHEMA aktx-20160630.xsd EX-101.SCH 35161
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aktx-20160630_cal.xml EX-101.CAL 29732
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aktx-20160630_def.xml EX-101.DEF 239850
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE aktx-20160630_lab.xml EX-101.LAB 273824
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aktx-20160630_pre.xml EX-101.PRE 280840
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K/A | Act: 34 | File No.: 001-36288 | Film No.: 17763046
SIC: 2834 Pharmaceutical Preparations